XLS |
Net sales, operating result (EBIT) and research and development costs, by business sector |
||||||||||
|
|
|
|
|
||||||
€ million |
Healthcare |
Life Science |
Performance Materials |
Group1 |
||||||
|
|
|
|
|
||||||
2016 |
|
|
|
|
||||||
|
||||||||||
Net sales |
6,855 |
5,658 |
2,511 |
15,024 |
||||||
Operating result (EBIT) |
1,593 |
556 |
823 |
2,481 |
||||||
R&D costs |
1,496 |
260 |
213 |
1,976 |
||||||
|
|
|
|
|
||||||
2017 |
|
|
|
|
||||||
Net sales |
6,999 |
5,882 |
2,446 |
15,327 |
||||||
Operating result (EBIT) |
1,447 |
834 |
689 |
2,525 |
||||||
R&D costs |
1,632 |
241 |
225 |
2,140 |